ScholarIQanswers from OpenAlex

Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities

PaperCitations, authors & open-access status

Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities have?

ScholarIQcitation count

Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities has 181 citations in the OpenAlex counts ScholarIQ stores.

When was Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities published?

ScholarIQyear

Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities has 2022 year in the ScholarIQ index.

What is the open-access status of Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities?

ScholarIQoa status

Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities has gold oa status in the ScholarIQ index.

What is the DOI of Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities?

ScholarIQdoi

The DOI for Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities is on the source record.

What is the PMID of Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities?

ScholarIQpmid

The PMID for Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities is on the source record.

What is the OpenAlex record for Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities?

ScholarIQopenalex

The OpenAlex for Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial